10 Stocks Under $1 That Will Explode

Page 8 of 8

1. Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH)

Share Price (As of January 8, 2026): $0.37

Upside Potential: 719.70%

Number of Hedge Fund Holders: 6

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) is one of the stocks under $1 that will explode.

As of the market open on January 9, 2026, Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) has surged roughly 37% in 2026 so far, showcasing a strong share price momentum.

However, at the same time, Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) is facing near-term regulatory challenges amid this share momentum, with the FDA recommending a second Phase 3 trial for brilaroxazine in schizophrenia. On December 23, 2025, the company saw H.C. Wainwright reiterate a ‘Buy’ rating with a $4 price target. The firm described the FDA guidance as consistent with precedent in schizophrenia drug development, projecting regulatory submission in late 2027, with potential approval and launch in late 2028.

Meanwhile, Roth Capital revisited Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) the following day, reducing its price target to $1.50, while reiterating a ‘Buy’ rating, according to TheFly. The firm cited anticipated equity dilution required to fund the second Phase 3 study, estimated at $60-75 million. Roth Capital remains optimistic about brilaroxazine’s therapeutic potential and has adjusted expectations following the FDA decision.

Additionally, Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) shared a brief update on the publication of vocal biomarker findings from the RECOVER trial. The update reinforces brilaroxazine’s efficacy assessment for negative symptoms and the progress on ongoing clinical development.

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) is focused on developing CNS, respiratory, and metabolic therapies. Using a proprietary chemical genomics platform, the company is advancing its RP5063 (brilaroxazine) and RP1208 pipelines.

While we acknowledge the potential of RVPH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RVPH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT12 Best Multibagger Stocks to Buy Heading into 2026 and 7 Best Rising Tech Stocks to Buy Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.

Page 8 of 8